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Acetaminophen-induced renal necrosis and insufficiency occurs in 
patients with acetaminophen overdose. Renal failure is rapidly assuming epidemic pro-
portions globally. In absence of reliable and effective nephroprotective drugs, strategies 
towards exploring alternative therapies for treatment of kidney diseases are essential. 
Asparagus racemosus is a medicinal plant used for treatment of various ailments. This 
research was undertaken to investigate the protective effect of ethanol fraction of A. 
racemosus roots extract in acetaminophen-induced uraemia and renal failure in rats. 
Rats were co-administered with acetaminophen injection and oral administration of A. 
racemosus roots extract in an attempt of protection against renal failure. Uremic biomark-
ers significantly decreased, and elevated levels of antioxidant enzymes were found, in the 
animals treated with ethanol fraction of A. racemosus when compared with acetamino-
phen treated uremic animals. Also, histology of kidneys showed control like structure in 
animals treated with this extract but severe damage in the uremic animals. HPLC analysis 
of the ethanol fraction of A. racemosus roots extract revealed eight compounds out of 
which one had a retention time near to the quercetin standard. It may be concluded 
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Introduction
Acetaminophen (N-acetyl-p-aminophenol; APAP), also 
known as paracetamol, is one of the most effective over-
the-counter analgesic-antipyretic chemotherapeutic 
agents belonging to the para-aminophenol class of the 
non-steroidal anti-inflammatory drugs (NSAIDs) (Hard-
man et al. 2001) and is considered safe at therapeutic dos-
ages. Acute and chronic high doses of APAP are known 
to cause hepatic necrosis in both animals and humans 
(O’Grady 1997), but impairment of renal function by 
acetaminophen as the main untoward effect is also be-
coming increasingly reported (McLaughlin et al. 1998; 
Fored et al. 2001).
Different research work done on the anti-uremic and 
nephroprotective phytochemicals from different plant 
extracts such as methanolic bark extract of Termina-
lia arjuna (Das et al. 2010a), methanolic root extract of 
Withania somnifera (Das et al. 2010b) which had been ef-
fective to reduce uremic toxins in experimentally induced 
renal failure in rats. Other research work, undertaken 
on nutraceuticals like alpha lipoic acid (Pradhan et al. 
2013) and on probiotic therapy (Mandal et al. 2013c) as 
an alternative; both the work was shown to have excellent 
nephroprotective activity against acetaminophen-induced 
renal failure in male rats.
In Indian system of medicine, Asparagus racemosus 
(Liliaceae) is an important medicinal plant having a wide 
range of biological activities (Goyal et al. 2003). The 
therapeutic components present in the root of A. racemosus 
are phytosterols, saponins, polyphenols, flavonoids and 
ascorbic acid (Visavadiya and Narsimhacharya 2005). The 
aim of the present study was to evaluate the protective 
effect of the ethanol fraction of A. racemosus roots (AR) 
against acetaminophen-induced nephrotoxicity in male 
albino rats by evaluating biochemical and histological 
alterations. HPLC analysis of phytochemicals to search out 




Drug and chemicals 
Acetaminophen (paracetamol, N-acetyl p-aminophenol; 
APAP) was purchased from AshChemie India (Thane, 
India). It was administered intraperitoneally with saline. 
All other chemicals and kits were obtained from Merck 
(Mumbai, India) and HiMedia Laboratories (Mumbai, 
India).
Plant materials 
The root of A. racemosus was collected from Gopali, Indian 
Institute of Technology, Kharagpur (Paschim Medinipur 
district, West Bengal). Plant material was identified by 
taxonomist at the Department of Botany, Raja N. L. Khan 
Women’s College, Midnapore. The voucher specimens 
were deposited at the Department of Botany (Raja N. L. 
Khan Women’s College).
Animal care and selection
The study was conducted on 24 healthy adult male albino 
rats of Wistar strain (Ghosh Animal, Kolkata 54, India) 
having a body weight of 90 ± 10 g. They were acclima-
tized to laboratory conditions for two weeks prior to 
experimentation. The animals were grouped and housed 
in polyacrylic cages (38 x 23 x 10 cm) three rats/cage in 
a temperature-controlled room (22 ± 2 °C) with 12-12 h 
dark-light cycles (8.00- 20.00 h light, 20.00-8.00 h dark) at 
a humidity of 50 ± 10%. They were provided with standard 
food and water ad libitum. Animal care (NIH 1985) was 
provided according to the guiding principle for the care 
and use of animals (Olfert et al. 1993). This experiment 
was approved by our Institutional Animal Ethical Com-
mittee according to the CPCSEA guidelines (CPCSEA 
Registration No- 1905/PO/Re/S/2016/CPCSEA).
Preparation of ethanol fraction of AR
Roots of A. racemosus were washed and cut into small pieces 
then shade dried and crushed in an electrical grinder. A 
total of 100 g powdered root material was washed in 400 
ml of hexane for 24 h to remove the greasy non-polar 
components. The hexane was discarded, and residue was 
dissolved in hydromethanol (methanol and water mixture 
4:6) for 2 h in a Soxhlet apparatus. Then the extract was 
filtered through Whatman No. 1 filter paper and the fil-
trate was evaporated in a rotary vacuum evaporator. Of 
this hydromethanol extract residue, 25 g was dissolved in 
500 ml ethyl acetate for 2 h in a Soxhlet apparatus. The 
extract was filtered, and the resulting filtrate was dried 
in the air. The ethyl acetate extract was then dissolved 
in 250 ml ethanol for 2 h in a Soxhlet apparatus. Then it 
was filtered, and the resulting filtrate was dried under 
reduced pressure at 40 °C on a rotary evaporator (Das et 
al. 2010b; Roy et al. 2014b; Roy et al. 2014a). The fraction 
was named as ethanol fraction of A. racemosus (AR) and 
it was stored in refrigerator for further study.
Grouping of animals
Twenty-four rats were divided into four groups. The dose 
of acetaminophen and AR was established in our labora-
tory according to OECD guidelines (Roy et al. 2015; Roy 
et al. 2014a), by acute and main toxicity study. The details 
of groups with the 10-days treatment are given in Table 1.
Animal scarification, plasma and organ collection
This experimental design was continued for 10 days. On 
the 11th day, the animals were sacrificed by exsanguina-
tions method and using chloroform anaesthesia. Blood 
was collected from the aorta for biochemical and haema-
tological analysis, after which the liver was collected for 
liver glutathione content and histopathological analysis. 
Blood was centrifuged at 10 000 g for 20 min at 4 °C and 
then plasma was collected.
Measurement of biochemical parameters
Plasma urea and creatinine level were measured by stan-
dard kit method (Pradhan et al. 2013; Burtis and Ashwood 
1999). Quantification of plasma sodium and potassium was 
done by standard kit methods using electrolyte analyser 
(Systronics, India) by using plasma samples (Sunderman 
1959; Roy et al. 2013). Activity of the antioxidant enzymes 
catalase (CAT; Pradhan et al. 2013; Beers and Sizer 1952), 
Groups Number of rats Treatments
Group I 6 rats Served as untreated control and was provided normal food and water.
Group II 6 rats Ethanol fraction of AR at 500 mg/kg body weight/day for 10 days was orally feeding to rats through 
gavage for 10 days. One g of ethanol fraction of AR was dissolved in 1 ml of deionized water.
Group III 6 rats Uremic animals were treated with intraperitoneal APAP injection at 500 mg/kg body weight/day once 
in every day for 10 consecutive days. One g of APAP was dissolved in 1 ml of deionized water.
Group IV 6 rats Orally feeding with ethanol fraction of AR at the dose of 500 mg/kg body weight/day with co admin-
istration of intraperitoneal APAP injection at 500 mg/kg body weight/day once in every day for 10 
consecutive days. 
Table 1. Grouping of animals with the treatment
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and superoxide dismutase (SOD; Marklund and Marklund 
1947; Roy et al. 2015), and GSH level (Elkarib 2014) were 
measured spectrophotometrically from plasma and kidney 
samples. SOD and CAT are the most important enzymes 
involved in ameliorating the effects of oxygen metabolism 
(Linares et al. 2006). The oxidative stress marker MDA 
was determined by UV-VIS spectrophotometer (Systron-
ics, India) as described in Roy et al. (2015) and Ohkawa 
et al. (1976). Histology of kidney tissue was performed 
by standard method (Roy et al. 2015; Mukherjee 2010).
Statistical analysis 
Analysis of variance (ANOVA) followed by a multiple 
two-tail t-test with Bonferroni modification was used 
for statistical analysis of the collected data.
HPLC analysis
HPLC analysis of AR was carried out on a Thermo Fisher 
HPLC system equipped with an ODS-2 250 x 4.6, 5 µm 
(Thermo Scientific, UK) reverse phase chromatographic 
column using UV detector at 254 nm. For the separation, 
4.6 mM, pH 7.2 phosphate buffer (A) and acetonitrile 
(B) were applied in the ratio of 1:1. The flow rate was 
1.5 ml/min at 37 °C and the injection volume was 20 µl. 
Concentration of test solution used for this study was 
50 mg dry weight/ml dissolved in methanol. The run 




BW was measured prior to experiment and final BW 
was taken before animal sacrification. Due to acetamin-
ophen-induced uraemia and oxidative stress, there was 
a decreased rate of body weight gain in uremic group in 
comparison to Group I, II and IV. Also, in Group IV, the 
animals’ BW was significantly (P < 0.05) increased when 
compared with Group III animals and it was similar to 
control group of animals as shown in Table 2. 
Antioxidants and lipid peroxidation
Activity of CAT and SOD, as well as GSH levels, were 
significantly (P < 0.05) decreased in the acetaminophen-
induced uremic Group III animals comparing control 
group of animals (Table 3 and 4). But on co administration 
of AR at 500 mg/kg BW/day for 10 days to the Group IV 
animals these antioxidant enzyme levels shifted towards 
control group of animals and increased significantly (P 
< 0.05) when compared with Group III.
Groups Initial body weight (g) Final body weight (g) Increase or decrease in body weight (g)
I 104.2 ± 2.5a 120.3 ± 5.3a 16.1
II 106.4 ± 3.8a 126.3 ± 4.7c 19.9
III 105.6 ± 3.6a 109.2 ± 3.2b 3.6
IV 106.7 ± 3.1a 122.5 ± 6.2a 15.8
Table 2. Effect of ethanol fraction of A. racemosus on body weight in rats with acetaminophen-induced renal failure. Data were expressed as mean ± SE 










I 0.92 ± 0.08a 0.97 ± 0.05a
II 0.94 ± 0.17a 0.96 ± 0.07a
III 0.13 ± 0.03b 0.26 ± 0.04b
IV 0.88 ± 0.06a 0.92 ± 0.07a
Table 3. Effect of ethanol fraction of A. racemosus on plasma and kidney 
catalase in rats with acetaminophen-induced renal failure. Data were ex-
pressed as mean ± SE (n = 6) and data with different superscripts (a and b) 
in a specific vertical column differ from each other significantly (p < 0.05).
Groups Plasma SOD(mmol of H2O2 consumption/dl of plasma/min)
Kidney SOD
(mmol of H2O2 consumption/mg of tissue/min)
Kidney GSH
(µmol/g of tissue)
I 0.95 ± 0.06a 1.31 ± 0.08a 19.53 ± 2.43a
II 0.98 ± 0.04a 1.38 ± 0.08a 20.03 ± 3.17a
III 0.48 ± 0.05b 0.55 ± 0.08b 5.44 ± 0.83b
IV 0.92 ± 0.07a 1.32 ± 0.07a 13.66 ± 1.58c
Table 4. Effect of ethanol fraction of A. racemosus on SOD and GSH level in rats with acetaminophen-induced renal failure. Data were expressed as mean 
± SE (n = 6) and data with different superscripts (a, b and c) in a specific vertical column differ from each other significantly (p < 0.05).
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Plasma and kidney MDA levels were increased sig-
nificantly (P < 0.05) in Group III animals in comparison 
to Group I, II and IV (Table 5). On oral administration 
of AR to Group IV animals, the levels of MDA decreased 
significantly (P < 0.05) in comparison to Group III (Table 
5) and the values were very near to the control. So, the 
ethanol fraction of AR significantly resettled the MDA 
value near to the control and prevented lipid peroxidation.
Renal function effects
There was a significantly (P < 0.05) higher plasma sodium, 
and lower plasma potassium, level in Group III animals 
in comparison to other groups (Table 6), indicating that 
electrolyte balance was hampered due to nephrotoxicity. 
In Group IV, co administered with AR and acetaminophen 
for 10 days, electrolyte imbalance was prevented.
There was also a significant (P < 0.05) increase in 
the plasma urea and creatinine concentrations in the 
Group III. In Group IV, urea and creatinine level was 
significantly (P < 0.05) decreased and was very close to 
the controls (Table 7). Administration of AR apparently 
exerts maximum antioxidative and antiuremic effects 
on APAP-induced uremic and oxidative damage in rats.
Histology
The histological pattern of the kidney in control and 
AR-treated rats showed normal tubular brush borders 
and intact glomeruli and Bowman’s capsule (Fig. 1A, B). 
APAP-induced uremic Group III animals showed kidney 
tissues with severe tubular necrosis and degeneration in 
the renal tissues (Fig. 1C): dilation in tubules (DT), dam-
aged glomeruli with a mild degree of swelling, necrosis and 
degranulation were present. Coadministration of AR for 
10 days in Group IV ameliorated the toxic manifestations 
of acetaminophen in the kidney, normal glomerulus (G) 
with organized normal tubules (T) were seen (Fig. 1D).
HPLC analysis
Analysis of AR revealed two major and six minor peaks 




I 132.3 ± 3.5a 4.76 ± 0.42a
II 134.2 ± 4.22a 4.87 ± 0.58a
III 182.72 ± 2.53b 2.67 ± 0.37b
IV 138.5 ± 6.3a 4.68 ± 0.47a
Table 6. Effect of ethanol fraction of A. racemosus on plasma sodium and 
potassium level in rats with acetaminophen-induced renal failure. Data were 
expressed as mean ± SE (n = 6). Data with different superscripts (a and b) 




I 22.5 ± 2.27a 0.36 ± 0.05a
II 20.08 ± 3.6b 0.37 ± 0.03b
III 66.2 ± 4.2b 1.27 ± 0.09a
IV 34.8 ± 2.5a 0.39 ± 0.02a
Table 7. Effect of ethanol fraction of A. racemosus on plasma urea and cre-
atinine level in rats with acetaminophen-induced renal failure. Data were 
expressed as mean ± SE (n = 6). Data with different superscripts (a and b) 
in a column differ from each other significantly (p < 0.05).
Figure 1. Histology of kidney tissues stained with hematoxylin and eosin 
magnified using a 40X objective. Figure 1A showing normal histology of kid-
ney of control group of rats with normal glomerulus (NG) and renal tubules 
(NT) are well organized in histoarchitecture. Figure 1B showing normal histol-
ogy of kidney of AR treated control group of rats with normal glomerulus 
(NG) and renal tubules (NT) are well organized in histoarchitecture. Figure 1C 
showing severe disorganization of rat kidney after acetaminophen injection 
of 500 mg/kg body weight to Group II rats, where damaged glomerulus (DG) 
and dilated renal tubules (DT) are seen. Figure 1D showing acetaminophen 
induced nephrotoxic rat kidney (500 mg/kg body weight) with treatment by 
AR (500 mg/kg) for 10 days to group IV rats showing control like histology 
with normal glomerulus (G) and renal tubule (T).
Groups Plasma MDA(nmol/dl of plasma) 
Kidney MDA
(nmol/mg of tissue)
I 20.9 ± 6.27a 26.9 ± 3.5a
II 23.5 ± 8.5b 26.7 ± 2.03b
III 49.02 ± 5.2b 63.4 ± 1. 9a
IV 23.8 ± 3.5a 42.1 ± 0.32a
Table 5. Effect of ethanol fraction of A. racemosus on plasma and kidney 
MDA level in rats with acetaminophen-induced renal failure. Data were 
expressed as mean ± SE (n = 6) and data with different superscripts (a and 
b) in a specific vertical column differ from each other significantly (p < 0.05).
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found at retention times of 1.849 and 3.334, respectively 
(Fig. 2). The quercetin standard had a HPLC chromato-
gram with three peaks (Fig. 3). The major compound of 
AR had a similar retention time (3.334) as found for the 
major compound of quercetin standard (3.507).
Discussion
Body weight gain decreased in uremic animals by re-
peated dose of acetaminophen due to oxidative stress, 
but co administration of ethanol fraction of AR brought 
the body weight back towards control.
Generation of reactive oxygen species has been pro-
posed as a mechanism by which different chemicals can 
induce nephrotoxicity (Somani et al. 2000). During kidney 
injury, superoxide radicals were generated in body and 
modulate SOD and CAT, resulting in the loss of activity 
and accumulation of superoxide radical, which damages 
kidney. Several pathways are known for acetaminophen 
metabolism. By sulfation and glucoronidation 90% of 
APAP is metabolized and about 5% via cytochrome P-450 
enzyme system (Slitt et al. 2005; Prescott 2005). Metabo-
lism by cytochrome P-450 produced N-acetyl-p-benzoqui-
none imine (NAPQI) which is a toxic metabolite to liver 
and kidney. At therapeutic doses, NAPQI is conjugated 
with reduced glutathione, an antioxidant compound, in 
the liver and NAPQI is excreted by the kidneys (da Silva 
Melo et al. 2006). At high doses, depletion of cellular GSH 
allows NAPQI to bind with cellular proteins and initi-
ate lipid peroxidation which leads to renal and hepatic 
injury. The high antioxidant enzyme levels in AR-treated 
animals might play a significant role in the mechanism of 
the nephroprotective effect of A. racemosus root extract. 
Oxidative stress and lipid peroxidation are early events 
related to free radicals generated in the metabolism of 
APAP. Free radical mediated chain reactions damage cell 
membrane, and MDA is the most important indicator 
for the degree of lipid peroxidation. Earlier studies have 
clearly demonstrated that acute APAP overdose increases 
the lipid peroxidation and suppresses the antioxidant 
defence mechanisms in renal tissues (Roy et al. 2013; 
Roy et al. 2014a). On oral administration of AR to Group 
IV animals, the levels of MDA decreased significantly 
in comparison to uremic animals (Group III). It was 
likely that the action of compounds present in this plant 
fraction is mainly related to its ability to scavenge lipid 
peroxidation-initiating agents.
The most important biochemical alteration in APAP-
induced nephrotoxicity is inhibition of Na+/K+-ATPase. 
This enzyme regulates intracellular electrolytes and 
cell volume. Its damage may lead to enhancement of the 
electrolyte imbalance across the tubular cell membrane 
leading to the cellular lysis and tissue injury. Furthermore, 
nephrotoxicity and oxidative stress causes interference in 
ADH secretion. This may result in loss of large volumes 
of dilute urine and consequent rise in plasma osmolality 
and serum sodium concentration.
Elevations in blood urea, serum creatinine and acute 
tubular necrosis were often associated with drug-induced 
nephrotoxicity (Pradhan et al. 2013; Roy et al. 2015). The 
therapeutic components present in the root of A. racemosus, 
i.e. phytosterols, saponins, polyphenols, flavonoids and 
ascorbic acid (Visavadiya and Narsimhacharya 2005; 
Roy et al. 2014b) may be responsible for reduction of the 
APAP-induced toxicity. 
Treatment with A. racemosus roots could have enhanced 
detoxification of APAP thereby maintaining the kidney 
architecture. The biochemical estimations were confirmed 
Figure 2. HPLC chromatogram of ethanol fraction of AR showing eight 
separate peaks.
Figure 3. HPLC chromatogram of standard quercetin with one distinct peak 
and other minor peaks.
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by the histological study of kidney tissues. Kidney sections 
of control groups (Fig. 1A, B) reveal normal kidney archi-
tecture with normal tubules and organized glomerulus. 
Kidney tissues of animals treated with APAP (Group 
III; Fig. 1C) showed loss of renal tubular architecture 
with dilated tubules and damages in glomeruli, and dif-
fuse degenerative changes. In the renal tubules, massive 
cellular swelling and narrowing of lumen was evident. 
There were focal areas of necrosis with accumulation of 
protein casts in the tubular lumen. Rats treated with AR 
for 10 days (Group IV; Figure 1D) showed normal renal 
tubular architecture with organized glomeruli, very near 
to normal animals, there was only a very low degree of 
cellular swelling. The protective effects of this plant could 
have been due to presence of flavonoids and antioxidants 
(Roy et al. 2014b). These findings suggest the nephropro-
tective potentials of AR against acetaminophen-induced 
uraemia and oxidative stress.
A. racemosus roots contain phenols and flavonoids, 
chiefly responsible for antioxidant activity (Roy et al. 
2014b). Also, the HPLC analysis of the ethanol fraction 
of AR showed that there was a major compound, which 
have similar retention time as quercetin, a flavonol from 
the flavonoid group of polyphenols. This compound may 
have comparable properties as quercetin, though further 
studies are necessary to identify this specific compound. 
In conclusion, result suggests that the ethanol fraction 
of A. racemosus roots has a nephroprotective potential 
which reduces biochemical and histological damages as-
sociated with APAP toxicity. Further studies are required 
to find out the active principles and their possible mecha-
nisms of action to aid the discovery of new therapeutic 
agents for the treatment of renal diseases.
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